|
Subsidised Ocrelizumab/Ocrevus in Australia
Ocrelizumab (marketed as Ocrevus) is now on the PBS list in Australia.
That means that it is now available for $A39.50 per script compared to $A$35,100 per year previously. Multiple sclerosis wonderdrug gets government subsidy Admins, I mistakenly posted this in the wrong forum - it belongs in the MS forum. Can you move it there please. Thanks. |
| All times are GMT -5. The time now is 10:59 AM. |
Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.